Evidence map›Paper›PMID 19240034›Full record

ArticleThe Journal of biological chemistry2009

Subunit and catalytic component stoichiometries of an in vitro reconstituted human pyruvate dehydrogenase complex.

Chad A Brautigam, R Max Wynn, Jacinta L Chuang, David T Chuang

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chad A BrautigamDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. chad.brautigam@utsouthwestern.edu
R Max Wynn
Jacinta L Chuang
David T Chuang

Funding

Structure and Function of Mitochondrial Protein KinasesR01DK062306 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI CHUANG, DAVID T · 2003 to 2018
$5.4M
INBORN ERRORS OF METABOLISM IN CELL CULTURER01DK026758 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI CHUANG, DAVID T · 1986 to 2010
$4.3M
Structure and Function of Mitochondrial Protein KinasesR56DK062306 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI CHUANG, DAVID T · 2008 to 2014
$397k
NIDDK NIH HHS DK26758NIDDK NIH HHS DK62306
6 · The paper itself

Abstract

The human pyruvate dehydrogenase complex (PDC) is a 9.5-megadalton catalytic machine that employs three catalytic components, i.e. pyruvate dehydrogenase (E1p), dihydrolipoyl transacetylase (E2p), and dihydrolipoamide dehydrogenase (E3), to carry out the oxidative decarboxylation of pyruvate. The human PDC is organized around a 60-meric dodecahedral core comprising the C-terminal domains of E2p and a noncatalytic component, E3-binding protein (E3BP), which specifically tethers E3 dimers to the PDC. A central issue concerning the PDC structure is the subunit stoichiometry of the E2p/E3BP core; recent studies have suggested that the core is composed of 48 copies of E2p and 12 copies of E3BP. Here, using an in vitro reconstituted PDC, we provide densitometry, isothermal titration calorimetry, and analytical ultracentrifugation evidence that there are 40 copies of E2p and 20 copies of E3BP in the E2p/E3BP core. Reconstitution with saturating concentrations of E1p and E3 demonstrated 40 copies of E1p heterotetramers and 20 copies of E3 dimers associated with the E2p/E3BP core. To corroborate the 40/20 model of this core, the stoichiometries of E3 and E1p binding to their respective binding domains were reexamined. In these binding studies, the stoichiometries were found to be 1:1, supporting the 40/20 model of the core. The overall maximal stoichiometry of this in vitro assembled PDC for E2p:E3BP:E1p:E3 is 40:20:40:20. These findings contrast a previous report that implicated that two E3-binding domains of E3BP bind simultaneously to a single E3 dimer (Smolle, M., Prior, A. E., Brown, A. E., Cooper, A., Byron, O., and Lindsay, J. G. (2006) J. Biol. Chem. 281, 19772-19780).

Indexed as

Binding SitesCatalysisDihydrolipoamide DehydrogenaseDihydrolipoyllysine-Residue AcetyltransferaseHumansIn Vitro TechniquesKineticsPyruvate Dehydrogenase ComplexPyruvate Dehydrogenase (Lipoamide)Recombinant ProteinsUltracentrifugationDihydrolipoamide DehydrogenaseDihydrolipoyllysine-Residue AcetyltransferasePyruvate Dehydrogenase ComplexPyruvate Dehydrogenase (Lipoamide)Recombinant Proteins

Identifiers

PMID19240034
PMCPMC2676041

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.